153 related articles for article (PubMed ID: 36376238)
1. Delay in desmopressin therapy: Disaster in waiting.
Kroll C; Zandvakili A
J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
3. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
4. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
5. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
6. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
Guo Q; Lu J; Mu Y; Dou J; Pan C
Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
[TBL] [Abstract][Full Text] [Related]
7. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
8. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
9. Survival with serum sodium level of 180 mEq/L: permanent disorientation to place and time.
Gomez-Daspet J; Elko L; Grebenev D; Vesely DL
Am J Med Sci; 2002 Dec; 324(6):321-5. PubMed ID: 12495299
[TBL] [Abstract][Full Text] [Related]
10. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
11. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
12. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
[TBL] [Abstract][Full Text] [Related]
13. Central diabetes insipidus following carbon monoxide poisoning.
Chang MY; Lin JL
Am J Nephrol; 2001; 21(2):145-9. PubMed ID: 11359023
[TBL] [Abstract][Full Text] [Related]
14. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
15. [Hypernatremia and polyuria in a female patient with an initial diagnosis of secondary acute myeloid leukemia].
Aydilek E; Jäger K; Xhaxho K; Akdas R; Wallbach M; Wulf G; Brökers N
Inn Med (Heidelb); 2022 Nov; 63(11):1194-1199. PubMed ID: 35925122
[TBL] [Abstract][Full Text] [Related]
16. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
18. Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: First experience in infants.
Lim WY; Riba-Wolman R
Clin Endocrinol (Oxf); 2020 Feb; 92(2):179-181. PubMed ID: 31715009
[No Abstract] [Full Text] [Related]
19. Diabetes insipidus and pregnancy.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2016 Jun; 77(2):135-8. PubMed ID: 27172867
[TBL] [Abstract][Full Text] [Related]
20. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
